These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 30706418)
1. The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria. Saleem T; Dahpy M; Ezzat G; Abdelrahman G; Abdel-Aziz E; Farghaly R Appl Biochem Biotechnol; 2019 Jul; 188(3):854-867. PubMed ID: 30706418 [TBL] [Abstract][Full Text] [Related]
2. Diabetes and branched-chain amino acids: What is the link? Bloomgarden Z J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529 [TBL] [Abstract][Full Text] [Related]
3. The Effect of Mild Renal Dysfunction on the Assessment of Plasma Amino Acid Concentration and Insulin Resistance in Patients with Type 2 Diabetes Mellitus. Ikeda H J Diabetes Res; 2022; 2022():2048300. PubMed ID: 35734236 [TBL] [Abstract][Full Text] [Related]
4. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy. Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368 [TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria. Yu Y; Suo L; Yu H; Wang C; Tang H Diabetes Res Clin Pract; 2004 Aug; 65(2):95-104. PubMed ID: 15223221 [TBL] [Abstract][Full Text] [Related]
6. Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy. Shiju TM; Mohan V; Balasubramanyam M; Viswanathan P J Diabetes Complications; 2015 Apr; 29(3):400-6. PubMed ID: 25619588 [TBL] [Abstract][Full Text] [Related]
7. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus. Pena MJ; Lambers Heerspink HJ; Hellemons ME; Friedrich T; Dallmann G; Lajer M; Bakker SJ; Gansevoort RT; Rossing P; de Zeeuw D; Roscioni SS Diabet Med; 2014 Sep; 31(9):1138-47. PubMed ID: 24661264 [TBL] [Abstract][Full Text] [Related]
8. Elabela levels in patients with type 2 diabetes: can it be a marker for diabetic nephropathy? Onalan E; Doğan Y; Onalan E; Gozel N; Buran I; Donder E Afr Health Sci; 2020 Jun; 20(2):833-840. PubMed ID: 33163050 [TBL] [Abstract][Full Text] [Related]
9. Decreased serum extracellular superoxide dismutase activity is associated with albuminuria in Chinese patients with type 2 diabetes mellitus. Feng G; Gao JL; Zhang P; Huang JJ; Huang LZ; Cheng L; Pu C Acta Diabetol; 2017 Nov; 54(11):1047-1055. PubMed ID: 28894973 [TBL] [Abstract][Full Text] [Related]
10. Serum Irisin and Diabetic Nephropathy in Patients with Diabetes Mellitus. Kawada T Horm Metab Res; 2021 Dec; 53(12):825. PubMed ID: 34891213 [TBL] [Abstract][Full Text] [Related]
11. Positive association of branched-chain amino acids with triglyceride and glycated haemoglobin in Indian patients with type 2 diabetes mellitus. Sankanagoudar S; Shukla R; Shukla KK; Sharma P Diabetes Metab Syndr; 2022 Apr; 16(4):102481. PubMed ID: 35427914 [TBL] [Abstract][Full Text] [Related]
12. Profile of plasma free amino acids, carnitine and acylcarnitines, and JAK2 Hassan MH; Galal O; Sakhr HM; Kamaleldeen EB; Zekry NF; Fateen E; Toghan R Biomed Chromatogr; 2023 Dec; 37(12):e5747. PubMed ID: 37728037 [TBL] [Abstract][Full Text] [Related]
13. Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus. Amanzadeh M; Mota A; Zarghami N; Abedi-Azar S; Abroon S; Akbarian N; Mihanfar A; Rahmati-Yamchi M Iran J Kidney Dis; 2018 Jan; 12(1):40-47. PubMed ID: 29421776 [TBL] [Abstract][Full Text] [Related]
14. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy. Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218 [TBL] [Abstract][Full Text] [Related]
15. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function. Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836 [TBL] [Abstract][Full Text] [Related]
16. Association between serum fibroblast growth factor 21 and diabetic nephropathy. Jian WX; Peng WH; Jin J; Chen XR; Fang WJ; Wang WX; Qin L; Dong Y; Su Q Metabolism; 2012 Jun; 61(6):853-9. PubMed ID: 22136913 [TBL] [Abstract][Full Text] [Related]
17. Association between insulin resistance and plasma amino acid profile in non-diabetic Japanese subjects. Yamada C; Kondo M; Kishimoto N; Shibata T; Nagai Y; Imanishi T; Oroguchi T; Ishii N; Nishizaki Y J Diabetes Investig; 2015 Jul; 6(4):408-15. PubMed ID: 26221519 [TBL] [Abstract][Full Text] [Related]
18. Correlation between serum YKL-40 levels and albuminuria in type 2 diabetes. Han JY; Ma XY; Yu LJ; Shao Y; Wang QY Genet Mol Res; 2015 Dec; 14(4):18596-603. PubMed ID: 26782508 [TBL] [Abstract][Full Text] [Related]
19. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus. Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152 [TBL] [Abstract][Full Text] [Related]
20. Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients. Fawzy MS; Abu AlSel BT J Diabetes Res; 2018; 2018():8517929. PubMed ID: 29850609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]